Methylfenidaat Hcl 1a Pharma 10 Mg, Tabletten

Methylphenidate Hydrochloride, the active ingredient in Methylfenidaat Hcl 1a Pharma 10 Mg, Tabletten, is a central nervous system stimulant presented as a 10 mg tablet for oral use. It treats attention deficit hyperactivity disorder and narcolepsy in children, adolescents and adults.

GNH USA supplies Methylfenidaat Hcl 1a Pharma 10 Mg, Tabletten as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Methylphenidate is a central nervous system stimulant indicated for disorders involving attention and wakefulness.

- Attention Deficit Hyperactivity Disorder (ADHD): improves attention, reduces hyperactivity and impulsivity in diagnosed patients. - Narcolepsy: decreases excessive daytime sleepiness and helps maintain wakefulness during the day.

Methylfenidaat Hcl 1a Pharma may cause a range of adverse reactions.

Common Side Effects: - Insomnia: difficulty falling or staying asleep. - Decreased appetite: reduced desire for food, potentially leading to weight loss. - Headache: mild to moderate head pain. - Nausea: feeling of stomach upset.

Serious or Rare Side Effects: - Cardiovascular events: hypertension, tachycardia, or arrhythmias. - Psychotic symptoms: hallucinations or severe mood changes. - Severe allergic reactions: rash, swelling, or anaphylaxis.

Before initiating therapy, several safety considerations should be reviewed.

- Cardiovascular assessment: evaluate blood pressure and heart rate, especially in patients with pre‑existing heart disease. - Growth monitoring: regularly track height and weight in children and adolescents. - Psychiatric history: assess for prior psychosis, mania, or severe anxiety. - Hypersensitivity: avoid use in individuals with known allergy to methylphenidate or excipients. - MAO‑inhibitor caution: ensure a minimum 14‑day washout period after discontinuing MAO inhibitors. - Store at ambient temperature: keep in the original pack, protect from moisture and excessive heat.

Methylfenidaat Hcl 1a Pharma can interact with several medication classes.

Major Interactions (Avoid): - MAO inhibitors: risk of hypertensive crisis when combined. - Sympathomimetic agents: may cause excessive cardiovascular stimulation. - Tricyclic antidepressants: can increase pressor response and heart rate.

Moderate Interactions (Monitor Closely): - Antihypertensives: methylphenidate may reduce their effectiveness. - Anticonvulsants: possible alteration of methylphenidate plasma levels. - CYP2D6 inhibitors: may raise methylphenidate concentrations, requiring dose adjustment.